Search for: "Astrazeneca"
Results 741 - 760
of 1,246
Sort by Relevance
|
Sort by Date
11 Mar 2011, 5:08 am
AstraZeneca promoted the drug, approved for schizophrenia and bipolar disorder, for dementia, depression and anxiety in violation of federal drug rules, according to the states.The company agreed to pay $68.5 million to 37 U.S. states and the District of Columbia to resolve allegations that the company deceptively marketed its anti-psychotic drug Seroquel. [read post]
9 Mar 2011, 3:00 am
(Spicy IP) Malta: ‘They shall not pass’ – Maltese court hands down decision in a cross-border seizure case (regarding trade marked pharmaceuticals) against defendant (IPKat) Peru: PIIPA helps get to the root of maca biopiracy (IP tango) US: IP position critical to biotech investment (PatentlyBIOtech) US: Schering files for PTA calculation correction in respect of patent covering ‘Thrombin receptor antagonists’ (Patent Docs) US: Cellectis files patent infringement… [read post]
1 Mar 2011, 7:35 am
" Astrazeneca AB, et. al. v. [read post]
24 Feb 2011, 1:49 pm
Astrazeneca Pharmaceuticals, 832 A.2d 1241, 1243 (Conn. [read post]
23 Feb 2011, 3:35 am
(Patentology) China: Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law (jiplp) US: Legislation to ban authorized generics during 180-day exclusivity period makes a comeback in Congress (FDA Law Blog) US: Market exclusivity, data exclusivity and S. 3921 (Holman’s Biotech IP Blog) US: President’s budget proposal increases funding for basic research but seeks to ‘trim’ data exclusivity period and pay-for-delay agreements (Patent… [read post]
18 Feb 2011, 6:11 am
AstraZeneca apologized to its schizophrenic pill-poppers to the tune of $150M. [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
15 Feb 2011, 4:06 am
AstraZeneca LP, 605 F.Supp.2d 669, 678-79 (W.D.Pa.2009) (discussing why the “professional paradigm” places the physician as the relevant decision maker in the health services industry), aff’d on other grounds, 372 Fed. [read post]
13 Feb 2011, 9:08 pm
Astrazeneca... [read post]
2 Feb 2011, 2:39 pm
AstraZeneca LP v. [read post]
27 Jan 2011, 8:22 am
AstraZeneca was forced to throw $520 million back into the trough because they "forgot" they were not permitted to market an anti-psychotic drug for uses never approved by the FDA. [read post]
27 Jan 2011, 8:22 am
AstraZeneca was forced to throw $520 million back into the trough because they "forgot" they were not permitted to market an anti-psychotic drug for uses never approved by the FDA. [read post]
26 Jan 2011, 1:31 am
In April of last year, we obtained a $520 million settlement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to resolve allegations that marketing of the anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA caused false claims to be submitted to federal health care programs. [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
23 Jan 2011, 10:35 am
See IPBiz post Teva makes paragraph IV filing against AstraZeneca over Seroquel [read post]
12 Jan 2011, 2:22 pm
AstraZeneca UK Ltd. [read post]
10 Jan 2011, 9:56 am
Bloomberg noted on 10 January 11:The antibody Synagis is made by AstraZeneca's Plc's Medimmune unit. [read post]
5 Jan 2011, 4:04 am
AstraZeneca UK... [read post]
5 Jan 2011, 1:34 am
General AUTM’s 2010 Better World Report highlights (PatentlyBIOtech) Drug R&D advocate named Kenyan ambassador to UN Geneva (IP Watch) US: Patent eligibility and In re Grams (Patent Docs) US: Main Hastings files false marking complaint against Pfizer based on products from its animal health division (Patent Docs) US: IDEXX files patent infringement complaint against Abbott Laboratories based on its sale of Architect HIV Ag/Ab Combo assay (Patent Docs) US: Life Technologies files patent… [read post]
31 Dec 2010, 3:57 am
Mylan has been sued by several other states, and last year pharmaceutical companies Mylan, AstraZeneca, and Johnson & Johnson agreed to pay $124 million in settlement of claims that the companies violated the U.S. [read post]
